Home

Anello rigido mostro pieno di speranza adpkd clinical trials Coloniale Devise Isolare

IJMS | Free Full-Text | Autosomal Dominant Polycystic Kidney Disease: From  Pathophysiology of Cystogenesis to Advances in the Treatment | HTML
IJMS | Free Full-Text | Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment | HTML

Clinical Trial End Points in ADPKD – AJKD Blog
Clinical Trial End Points in ADPKD – AJKD Blog

Research Pipeline | PKD Foundation
Research Pipeline | PKD Foundation

Long-term trajectory of kidney function in autosomal-dominant polycystic  kidney disease - Kidney International
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease - Kidney International

Medical trials on new therapies for ADPKD. | Download Table
Medical trials on new therapies for ADPKD. | Download Table

Clinical Trial End Points in ADPKD – AJKD Blog
Clinical Trial End Points in ADPKD – AJKD Blog

FDA Qualifies Total Kidney Volume as a Prognostic Biomarker for use in Clinical  Trials for Polycystic Kidney Disease | Critical Path Institute
FDA Qualifies Total Kidney Volume as a Prognostic Biomarker for use in Clinical Trials for Polycystic Kidney Disease | Critical Path Institute

Rapid progression of polycystic kidney disease during treatment with tumour  necrosis factor-neutralising antibodies | Nefrología
Rapid progression of polycystic kidney disease during treatment with tumour necrosis factor-neutralising antibodies | Nefrología

Treatment Strategies and Clinical Trial Design in ADPKD - Advances in  Chronic Kidney Disease
Treatment Strategies and Clinical Trial Design in ADPKD - Advances in Chronic Kidney Disease

PLOS ONE: Kidney volume measurement methods for clinical studies on  autosomal dominant polycystic kidney disease
PLOS ONE: Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease

Yinang formulation versus placebo granules as a treatment for chronic  kidney disease stages III–IV in patients with autosomal dominant polycystic  kidney disease: study protocol for a double-blind placebo-controlled  randomized clinical trial
Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III–IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial

CJASN on Twitter: "A Post Hoc Analysis of #Statin Use in Tolvaptan  Autosomal Dominant Polycystic Kidney Disease Pivotal Trials  https://t.co/vSKnGtOGtv #ADPKD Podcast: https://t.co/C4Np5ZuSSe  https://t.co/QOidLSF9tP" / Twitter
CJASN on Twitter: "A Post Hoc Analysis of #Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials https://t.co/vSKnGtOGtv #ADPKD Podcast: https://t.co/C4Np5ZuSSe https://t.co/QOidLSF9tP" / Twitter

Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney  Disease: An International Delphi Survey - American Journal of Kidney  Diseases
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey - American Journal of Kidney Diseases

CKD in Autosomic Dominant Polycystic Kidney Disease | IJGM
CKD in Autosomic Dominant Polycystic Kidney Disease | IJGM

A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan  in ADPKD - ScienceDirect
A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD - ScienceDirect

Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in  the Multicenter TAME-PKD Clinical Trial | American Society of Nephrology
Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical Trial | American Society of Nephrology

Randomised controlled trial to determine the efficacy and safety of  prescribed water intake to prevent kidney failure due to autosomal dominant polycystic  kidney disease (PREVENT-ADPKD) | BMJ Open
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD) | BMJ Open

Landmark Trials in ADPKD: Close, But No Cigar - Renal Fellow Network
Landmark Trials in ADPKD: Close, But No Cigar - Renal Fellow Network

ADPKD – Landmark Nephrology
ADPKD – Landmark Nephrology

Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review  - Kidney Medicine
Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review - Kidney Medicine

ADPKD — Blog — NephJC
ADPKD — Blog — NephJC

Biological Efficacy and Safety of Niacinamide in Patients With ADPKD -  Kidney International Reports
Biological Efficacy and Safety of Niacinamide in Patients With ADPKD - Kidney International Reports

Landmark Trials in ADPKD: Close, But No Cigar - Renal Fellow Network
Landmark Trials in ADPKD: Close, But No Cigar - Renal Fellow Network